ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment
The study is conducted to confirm equivalence between QL1012 (a new biosimilar formulation of Recombinant Human Follicle-stimulating Hormone) and Gonal-f® with respect to the number of oocytes retrieved in women for assisted reproductive treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring#1137441
- NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles#851386
- A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants#1044432
- Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval#1059399
- An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques#812149
Record · ID 1030079
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive